BerandaGIFOF • OTCMKTS
add
Grifols SA Preference Shares Class B
Tutup sebelumnya
$7,42
Rentang tahun
$5,58 - $9,40
Kapitalisasi pasar
5,97Â M USD
Volume Rata-Rata
10,00
Rasio P/E
-
Hasil dividen
-
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
(EUR) | Sep 2024info | Perubahan Y/Y |
---|---|---|
Pendapatan | 1,79Â M | 12,24% |
Biaya operasional | 376,78Â jt | -3,08% |
Laba bersih | 51,69Â jt | -13,19% |
Margin laba bersih | 2,88 | -22,79% |
Penghasilan per saham | — | — |
EBITDA | 468,09Â jt | 33,73% |
Tarif pajak efektif | 31,35% | — |
Neraca
Total aset
Total liabilitas
(EUR) | Sep 2024info | Perubahan Y/Y |
---|---|---|
Investasi tunai jangka pdk | 806,74Â jt | 66,60% |
Total aset | 20,28Â M | -8,07% |
Total liabilitas | 12,29Â M | -8,95% |
Total ekuitas | 8,00 M | — |
Saham yang beredar | 679,63 jt | — |
Harga terhadap nilai buku | 0,94 | — |
Tingkat pengembalian aset | 4,22% | — |
Tingkat pengembalian modal | 4,78% | — |
Arus Kas
Perubahan kas bersih
(EUR) | Sep 2024info | Perubahan Y/Y |
---|---|---|
Laba bersih | 51,69Â jt | -13,19% |
Kas dari operasi | 299,61Â jt | 92,51% |
Kas dari investasi | -196,40Â jt | -59,83% |
Kas dari pembiayaan | -1,56Â M | -1.860,81% |
Perubahan kas bersih | -1,47Â M | -3.652,69% |
Arus kas bebas | 243,60Â jt | 627,76% |
Tentang
Grifols, S.A. is a global healthcare company and manufacturer of plasma-derived medicines founded in Barcelona, Spain, in 1909. With a workforce of over 23,000employees, Grifols serves more than 110 countries and regions and maintains a direct presence in over than 30.
Principally a producer of blood plasma–based products, a field in which it is the European leader and third largest worldwide, and other biopharmaceutical solutions, the company is also a leader in transfusion medicine, supplying devices, instruments and reagents for clinical testing laboratories, in addition to clinical diagnostic technologies. Its portfolio of solutions is designed to enhance safety from donation to transfusion. Grifols also provides high-quality biological supplies for life-science research, clinical trials and for manufacturing pharmaceutical and diagnostic products. Additionally, the company supply tools, information and services that enable hospitals, pharmacies and healthcare professionals to deliver expert medical care. Wikipedia
CEO
Didirikan
18 Nov 1940
Situs
Karyawan
23.000